Skip to content
Screener

Total Revenue at other companies

Merck & Co. logo
Merck & Co.MRK
$16.61B+5.1%
Zoetis logo
ZoetisZTS
$2.47B-0.2%
Neogen logo
NeogenNEOG
$211.2M-4.4%
Balchem logo
BalchemBCPC
$270.71M+8.1%
Petco Health and Wellness Company, Inc. logo
Petco Health and Wellness Company, Inc.WOOF
$1.5B+0.2%
Archer Daniels Midland logo
Archer Daniels MidlandADM
$22.68B+7.2%

Segments

By product

See full
Medicated Feed Additives And Others$205.79M+13.3%
Mineral Nutrition$73.42M+9.9%
Nutritional Specialties$46.81M+8.0%
Vaccines$38.63M+15.7%
Performance Products$18.9M-16.6%

By segment

See full
Animal Health$291.23M+12.7%
Mineral Nutrition$73.42M+9.9%
Performance Products$18.9M-16.6%

By geography

See full
Latin America And Canada$75.62M+6.9%
EMEA$44.47M+14.3%
Asia Pacific$30.69M+8.7%

Other financials

Income statement

See full
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.44B+34.1%
Enterprise value$1.42B+33.1%
P/E15.1×-7.1×
P/S+0.1×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:25 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056280
For the Periods Ended March 31Three Months / 2026Three Months / 2025Nine Months / 2026Nine Months / 2025
Net sales$383,543$347,825$1,121,346$917,518
Cost of goods sold257,868243,257743,232627,585
Gross profit125,675104,568378,114289,933
Selling, general and administrative expenses81,02271,053231,875213,186
Operating income44,65333,515146,23976,747
Interest expense, net10,4319,35534,24625,992
Foreign currency losses (gains), net1,909(5,528)6,9886,609
Income before income taxes32,31329,688105,00544,146

Item 1. Financial Statements (unaudited)

FAQ

What is Phibro Animal Health's total revenue?
Phibro Animal Health (PAHC) reported total revenue of $383.54M in Q1 2026.
How has Phibro Animal Health's total revenue changed year-over-year?
Phibro Animal Health's total revenue increased by 10.3% year-over-year, from $347.83M to $383.54M.
What is the long-term trend for Phibro Animal Health's total revenue?
Over 3 years (2022 to 2025), Phibro Animal Health's total revenue has grown at a 11.2% compound annual growth rate (CAGR), from $942.26M to $1.3B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Phibro Animal Health's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude